Doctors Food Physicians Prescription 
World of DTC Marketing
JULY 17, 2022
Unpaid celebrity endorsements include venture capitalist Marc Andreessen, who says the drug completely changed his relationship with food, and Elon Musk, who has cited it on Twitter. But before the company can make Wegovy mainstream, it has to convince doctors to prescribe it and insurers and governments to pay for it.
World of DTC Marketing
JULY 5, 2022
Pharma websites provide the prescription that can help people overcome health problems but too often, they ignore the patient’s responsibility to lose weight and exercise. While the population is more worried about COVID, they are killing themselves by overeating processed food and not getting any exercise.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
OCTOBER 1, 2022
The US Food and Drug Administration (FDA) has granted approval for Amylyx Pharmaceuticals’ Relyvrio (sodium phenylbutyrate and taurursodiol) to treat adult patients with amyotrophic lateral sclerosis (ALS). A progressive and fatal neurodegenerative ailment, ALS is caused by the death of motor neurons in the brain and spinal cord.
Pharmaceutical Representative Training
DECEMBER 28, 2021
Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines. The technology identifies.
World of DTC Marketing
MAY 11, 2021
The COVID pandemic hopefully will be winding down soon and as people are returning to the doctors offices they are being diagnosed with a chronic health conditions, many of which can be prevented. Physicians are too afraid to tell patients that they are headed for health problems, and insurers aren’t proactive enough with customers.
pharmaphorum
AUGUST 11, 2022
More than 60 percent of all American adults take prescription drugs , amounting to approximately 131 million individuals. Doctors can also cut down on the guesswork involved in finding treatments, enabling them to see more patients. billion in the United States alone.
Pharmaceutical Technology
AUGUST 12, 2022
In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research. In the US, most physicians can only spend a day a week, which isn’t efficient, she says. “We
Expert insights. Personalized for you.
209 
Let's personalize your content